Sanofi-Genzyme Update – Tender Due Tomorrow!

April 6, 2011

As I’ve posted about before, Sanofi and Genzyme are merging.  This deal has taken awhile, and is structured as a tender offer.  It’s for $74 per share in cash, but also comes with a contingent value right that will be valuable if certain Genzyme drugs make it to market.  Interesting deal.

Shareholders wishing to tender their shares need to do so before 6 p.m. tomorrow.  If, all in all, Sanofi ends up with more than 90%, shareholders will get the same value via short-form merger (it is an easy concept, but I will explain in a future post).


{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: